Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Guillain-Barre Syndrome Reported After COVID Vaccine

Summary by Cindy Olmstead

A 60-year-old woman with a history of migraines who received the Johnson & Johnson one-dose COVID-19 vaccine developed Guillain-Barré syndrome (GBS) 10 days after receiving the vaccine in a clinical trial in Boston. The patient recovered from GBS after intravenous immunoglobulin (IVIG) treatment, said Dr. Anthony Amato of Harvard Medical School in Boston, adding that it was unlikely the vaccine caused GBS. A test to detect SARS-CoV-2 was repeated twice during the patient’s...